Literature DB >> 1377290

The effect of digital rectal examination on the serum prostate specific antigen concentration: results of a randomized study.

F M Chybowski1, E J Bergstralh, J E Oesterling.   

Abstract

To determine the effect of digital rectal examination on the serum prostate specific antigen (PSA) concentration a prospective, randomized, controlled trial involving 143 patients was conducted. Of the patients 86 (60%) had benign prostatic hyperplasia (BPH), 47 (33%) had prostate cancer and 10 (7%) had chronic prostatitis. The study group consisted of 71 men, all of whom had a serum PSA determination followed by a digital rectal examination and then a second serum PSA determination. The control cohort consisted of 72 men, all of whom had 2 serum PSA determinations without an intervening digital rectal examination. The median change in the serum PSA level for the study group was 0.4 ng./ml. compared to -0.1 ng./ml. for the control cohort (p less than 0.0001). For 76% of the study patients the second serum PSA level was greater than the initial value; only 32% of the control patients exhibited a higher second serum PSA level than the initial level (p less than 0.0001). However, only 4 patients with an initial PSA value in the reference range (0.0 to 4.0 ng./ml.) had a post-digital rectal examination value greater than 4.0 ng./ml. and only 1 patient whose presenting serum value was less than 10.0 ng./ml. had a serum PSA level greater than this cutoff point after digital rectal examination. This minimal change in serum PSA after digital rectal examination was independent of the diagnosis (BPH, cancer or chronic prostatitis), initial serum PSA concentration and examiner. Thus, although digital rectal examination had a statistically significant effect on the serum PSA concentration, the clinical significance of a 0.4 ng./ml. median increase appears inconsequential. Based on these findings, physicians should be confident that the serum PSA concentration in the immediate post-digital rectal examination period is accurate and does not compromise clinical use of the tumor marker.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1377290     DOI: 10.1016/s0022-5347(17)36517-5

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  8 in total

1.  The effects of ejaculation on serum prostate-specific antigen (PSA).

Authors:  I Yavaşçaoglu; V Savci; B Oktay; U Simşek; M Ozyurt
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

2.  The effect of digital rectal exam on the 4Kscore for aggressive prostate cancer.

Authors:  Michael A Maccini; Nicholas J Westfall; Adrie Van Bokhoven; Marshall Scott Lucia; Wendy Poage; Paul D Maroni; Shandra S Wilson; Leonard Michael Glodé; Paul Arangua; Jay Newmark; Mitchell Steiner; Priya N Werahera; Elward David Crawford
Journal:  Prostate       Date:  2018-02-19       Impact factor: 4.104

3.  A large, benign prostatic cyst presented with an extremely high serum prostate-specific antigen level.

Authors:  Han-Kuang Chen; Richard Pemberton
Journal:  BMJ Case Rep       Date:  2016-01-08

4.  Does Rigid Cystoscopy Affect the Total Serum Prostate-Specific Antigen Levels?

Authors:  Iqbal Singh; Ravi Prasad; Vivek Agarwal; R L Tripathi
Journal:  Indian J Surg       Date:  2013-02-15       Impact factor: 0.656

5.  A Review on the Clinical Utility of PSA in Cancer Prostate.

Authors:  Mohan Adhyam; Anish Kumar Gupta
Journal:  Indian J Surg Oncol       Date:  2012-03-03

6.  Urinary prostate-specific antigen and microseminoprotein-beta levels in men with and without prostate cancer: A prospective cohort study.

Authors:  Prashant Shrivastava; Harshit Garg; Madhusudan Bhat; Amit Dinda; Rajeev Kumar
Journal:  Indian J Urol       Date:  2020 Jan-Mar

7.  A Comprehensive Genome-Wide and Phenome-Wide Examination of BMI and Obesity in a Northern Nevadan Cohort.

Authors:  Karen A Schlauch; Robert W Read; Vincent C Lombardi; Gai Elhanan; William J Metcalf; Anthony D Slonim; Joseph J Grzymski
Journal:  G3 (Bethesda)       Date:  2020-02-06       Impact factor: 3.154

Review 8.  Prostate cancer biology & genomics.

Authors:  Hayley Whitaker; Joseph O Tam; Martin J Connor; Alistair Grey
Journal:  Transl Androl Urol       Date:  2020-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.